[EN] TETRAHYDROISOQUINOLINE COMPOUNDS AND THEIR USE AS PYRUVATE DEHYDROGENASE KINASE INHIBITORS<br/>[FR] COMPOSÉS TÉTRAHYDROISOQUINOLÉINE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE LA PYRUVATE DÉSHYDROGÉNASE KINASE
申请人:VERNALIS R & D LTD
公开号:WO2015040424A1
公开(公告)日:2015-03-26
A compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein: R1 is H, Cl, F, CH3 or CF3; R2 is H, C1-C6 alkyl or optionally substituted heteroaryl or optionally substituted aryl; and R3 is (Alk)n-Rn-(Alk)n-Rn-(Alk)n-X. The compounds are useful as tetrahydroisoquinoline (THQ) compounds, which are suitable for use as PDK inhibitors, for example for inhibition of cancer cell proliferation.
一种具有以下化学式(I)的化合物或其药用可接受的盐,其中:R1为H、Cl、F、CH3或CF3;R2为H、C1-C6烷基或可选择取代的杂环烷基或可选择取代的芳基;R3为(Alk)n-Rn-(Alk)n-Rn-(Alk)n-X。这些化合物可用作四氢异喹啉(THQ)化合物,适用于用作PDK抑制剂,例如用于抑制癌细胞增殖。